Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 9,422 | 18,821 | 7,279 | 7,093 | 8,479 |
| Operating Income | -9,422 | -18,821 | -7,279 | -7,093 | -8,479 |
| Interest Expense | 967 | 919 | 397 | 0 | 0 |
| Other Income | 729 | 603 | 252 | 75 | 6 |
| Pre-tax Income | -9,660 | -19,138 | -7,425 | -7,018 | -8,474 |
| Income Tax | N/A | N/A | N/A | -1,199 | N/A |
| Net Income Continuous | -9,660 | -19,138 | -7,425 | -5,819 | -8,474 |
| Net Income | $-9,660 | $-19,138 | $-7,425 | $-5,819 | $-8,474 |
| EPS Basic Total Ops | -0.32 | -0.65 | -0.26 | -0.20 | -0.32 |
| EPS Basic Continuous Ops | -0.32 | -0.64 | -0.26 | -0.20 | -0.32 |
| EPS Diluted Total Ops | -0.32 | -0.65 | -0.26 | -0.20 | -0.32 |
| EPS Diluted Continuous Ops | -0.32 | -0.64 | -0.26 | -0.20 | -0.32 |
| EBITDA(a) | $-9,286 | $-18,699 | $-7,169 | $-7,093 | $-8,479 |